Streaming Web-based Exercise At Home: A Pilot Study
IIT2019-14-SHIRAZIP-SWEAT: Streaming Web-based Exercise At Home: A Pilot Study
1 other identifier
interventional
12
1 country
1
Brief Summary
This is a single-arm pilot study to evaluate the use of web-based video conferencing as a method of exercise training delivery. This study will include 10 female breast cancer survivors and 10 male prostate cancer survivors. For the first 12 weeks on study (Part 1), participants will train with an exercise physiologist (EP) for 150 minutes/week. This training will be delivered by web-based video conferencing. For the next 12 weeks (Part 2), participants will be instructed to do patient-directed exercise.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for early_phase_1 prostate-cancer
Started Jul 2020
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 20, 2020
CompletedFirst Posted
Study publicly available on registry
February 25, 2020
CompletedStudy Start
First participant enrolled
July 7, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 30, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
March 30, 2023
CompletedApril 11, 2023
April 1, 2023
2.7 years
February 20, 2020
April 10, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Attendance
Explore adherence to intervention delivery measured through attendance (frequency of Skype sessions attended and fully completed)
12 weeks
Adherence
Explore adherence to intervention delivery measured through retention (participation from baseline through final assessment)
12 weeks
Patient consent
Explore adherence to intervention delivery measured through percentage of patients approached who sign consent
1 day
Manipulation check
Explore adherence to intervention delivery measured through scores on manipulation check after each session (2 questions asked by exercise physiologist on sound and visual clarity of the session)
12 weeks
Secondary Outcomes (13)
Changes in oxygen uptake (baseline - mid-study visit)
12 weeks
Changes in oxygen uptake (mid-study visit - end of study visit)
12 weeks
Changes in oxygen uptake (baseline - end of study visit)
24 weeks
Changes in strength test (baseline - mid-study visit)
12 weeks
Changes in strength test (mid-study visit - end of study visit)
12 weeks
- +8 more secondary outcomes
Study Arms (1)
Exercise
EXPERIMENTALFor the first 12 weeks on study (Part 1), participants will train with an exercise physiologist (EP) for 150 minutes/week. This training will be delivered by web-based video conferencing. For the next 12 weeks (Part 2), participants will be instructed to do patient-directed exercise.
Interventions
For the first 12 weeks on study (Part 1), participants will train with an exercise physiologist for 150 minutes/week. This training will be delivered by web-based video conferencing. For the next 12 weeks (Part 2), participants will be instructed to do patient-directed exercise.
Eligibility Criteria
You may qualify if:
- Male previously diagnosed with prostate cancer or female previously diagnosed with breast cancer.
- For breast cancer, minimum of 3 months post-active treatment completion. Active treatment includes chemotherapy, biologic therapy, radiation therapy, surgery, and any combination. Long-term hormonal/biologic treatments are acceptable.
- For prostate cancer, minimum of 3 months post-active treatment completion. Active treatment includes chemotherapy, biologic therapy, radiation therapy, surgery, and any combination. Long-term hormonal/biologic treatments are acceptable, except for androgen receptor-targeted therapies (such as enzalutamide, apalutamide, darolutamide, or abiraterone). Patients currently on active surveillance are eligible even if they have not received prior anti-cancer treatment.
- Has access to tablet, laptop, or desktop computer with video capabilities connected to the internet with a screen at least 13 inches across.
- Physically able to complete modified Bruce submaximal treadmill test, leg strength test, grip strength test, and InBody per patient self-assessment.
- Physician clearance to participate in this study. Can be done through review of patients' medical records.
- Ability to read, write, and understand English.
- Has a chair at home to use for exercise that is not on wheels and has a solid back (not a reclining chair).
- Ambulatory without assistance.
- Has a clear 5 x 6-foot space at home in which to exercise.
- Age \>18 years.
- Written informed consent obtained from subject and ability for subject to comply with the requirements of the study.
You may not qualify if:
- Active treatment planned within the next 6 months. Active treatment includes chemotherapy, biologic therapy, radiation therapy, surgery, and any combination. Long-term hormonal/biologic treatments are acceptable, except for AR-targeted therapies for prostate cancer.
- Known metastatic disease.
- Grade 3 or higher peripheral neuropathy.
- Major surgery within 3 months of baseline visit.
- Positive pregnancy test for women of child-bearing potential.
- Answers yes to any question on the Physical Activity Readiness Questionnaire unless study participation is cleared by a physician.
- Known allergy to Fitbit device.
- Currently meeting physical activity guidelines (score of \>23 on Godin-Shephard Leisure-Time Physical Activity Questionnaire).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Cedars Sinai Medical Center
Los Angeles, California, 90048, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Celina Shirazipour, PhD
Cedars-Sinai Medical Center
Study Design
- Study Type
- interventional
- Phase
- early phase 1
- Allocation
- NA
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
February 20, 2020
First Posted
February 25, 2020
Study Start
July 7, 2020
Primary Completion
March 30, 2023
Study Completion
March 30, 2023
Last Updated
April 11, 2023
Record last verified: 2023-04